208 related articles for article (PubMed ID: 9371802)
41. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase.
Navaratnam N; Morrison JR; Bhattacharya S; Patel D; Funahashi T; Giannoni F; Teng BB; Davidson NO; Scott J
J Biol Chem; 1993 Oct; 268(28):20709-12. PubMed ID: 8407891
[TBL] [Abstract][Full Text] [Related]
42. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
Lellek H; Kirsten R; Diehl I; Apostel F; Buck F; Greeve J
J Biol Chem; 2000 Jun; 275(26):19848-56. PubMed ID: 10781591
[TBL] [Abstract][Full Text] [Related]
43. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.
Sowden M; Hamm JK; Spinelli S; Smith HC
RNA; 1996 Mar; 2(3):274-88. PubMed ID: 8608451
[TBL] [Abstract][Full Text] [Related]
44. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
45. Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro.
Mehta A; Banerjee S; Driscoll DM
J Biol Chem; 1996 Nov; 271(45):28294-9. PubMed ID: 8910449
[TBL] [Abstract][Full Text] [Related]
46. Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.
Galloway CA; Ashton J; Sparks JD; Mooney RA; Smith HC
Biochim Biophys Acta; 2010 Nov; 1802(11):976-85. PubMed ID: 20541607
[TBL] [Abstract][Full Text] [Related]
47. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
[TBL] [Abstract][Full Text] [Related]
48. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
49. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
50. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes.
Tian N; Li X; Luo Y; Han Z; Li Z; Fan C
Mol Med Rep; 2014 Jan; 9(1):132-6. PubMed ID: 24173373
[TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein B messenger RNA editing: an update.
Chan L
Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
[TBL] [Abstract][Full Text] [Related]
52. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
Navaratnam N; Fujino T; Bayliss J; Jarmuz A; How A; Richardson N; Somasekaram A; Bhattacharya S; Carter C; Scott J
J Mol Biol; 1998 Jan; 275(4):695-714. PubMed ID: 9466941
[TBL] [Abstract][Full Text] [Related]
53. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site.
Navaratnam N; Bhattacharya S; Fujino T; Patel D; Jarmuz AL; Scott J
Cell; 1995 Apr; 81(2):187-95. PubMed ID: 7736571
[TBL] [Abstract][Full Text] [Related]
54. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
Hersberger M; Innerarity TL
J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
[TBL] [Abstract][Full Text] [Related]
55. Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine.
Giannoni F; Chou SC; Skarosi SF; Verp MS; Field FJ; Coleman RA; Davidson NO
J Lipid Res; 1995 Aug; 36(8):1664-75. PubMed ID: 7595088
[TBL] [Abstract][Full Text] [Related]
56. Hypermutation induced by APOBEC-1 overexpression can be eliminated.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Csako G; Patterson AP
RNA; 2010 May; 16(5):1040-52. PubMed ID: 20348446
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
Davidson NO; Anant S; MacGinnitie AJ
Curr Opin Lipidol; 1995 Apr; 6(2):70-4. PubMed ID: 7773570
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes.
Greeve J; Lellek H; Rautenberg P; Greten H
Biol Chem; 1998; 379(8-9):1063-73. PubMed ID: 9792439
[TBL] [Abstract][Full Text] [Related]
59. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
60. A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.
Mehta A; Driscoll DM
Mol Cell Biol; 1998 Aug; 18(8):4426-32. PubMed ID: 9671452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
